5888
E. Baloglu et al. / Bioorg. Med. Chem. Lett. 14 (2004) 5885–5888
ston, D. G. I.; Chaudhary, A. G.; Chordia, M. D.;
References and notes
Gharpure, M.; Gunatilaka, A. A. L.; Higgs, P. I.; Rimoldi,
J. M.; Samala, L.; Jagtap, P. J. J. Med. Chem. 1998, 41,
3715–3726.
1. (a) Kohler, G.; Milstein, C. Nature 1975, 256, 495–497; (b)
Carter, P. Nat. Rev. Cancer 2001, 1, 118–129; (c) Dillman,
R. O. Cancer Invest. 2001, 19, 833–841.
2. (a) Chari, R. V. J. Adv. Drug Deliver. Rev. 1998, 31, 89–
104; (b) Allen, T. M. Nat. Rev. Cancer 2002, 2, 750–763.
3. Blattler, W. A.; Chari, R. V. J. In Anticancer Agents
Frontiers in Cancer Chemotherapy; Ojima, I., Vie, G. D.,
Altmann, K. H., Eds.; ACS Symposium Series 796;
American Chemical Society: Washington, DC, 2001; p
317.
8. Holton, R. A.; Zhang, Z.; Clarke, P. A. H. N.; Procter, D.
J. Tetrahedron Lett. 1998, 39, 2883.
9. (a) Ojima, I.; Habus, I.; Zhao, M.; Zucco, M.; Park, Y. H.;
Sun, C. M.; Brigaud, T. Tetrahedron 1992, 48, 6985–7012;
(b) Ojima, I.; Sun, C. M.; Zucco, M.; Park, Y. H.; Duclos,
O.; Kuduk, S. Tetrahedron Lett. 1993, 34, 4149–4152; (c)
Ojima, I. Acc. Chem. Res. 1995, 28, 383; (d) Ojima, I.;
Delaloge, F. Chem. Soc. Rev. 1997, 26, 377–386; (e)
Holton, R. A.; Biediger, R. J.; Boatman, P. D. In Taxol:
Science and Applications; Suffness, M., Ed.; CRC Press:
New York, 1995; pp 97–121, andreferences citedtherein;
(f) Brieva, R.; Crich, J. Z.; Sih, C. J. J. Org. Chem. 1993,
58, 1068–1075.
10. The in vitro cytotoxicities of these new taxoids were
evaluatedusing a clonogenic assay. Cells were platedin
six-well tissue culture plates andexposedfor 72h to the
taxoid. The medium was then replaced and the cells were
incubateduntil colonies hadformed(5–10adys). Cells
were then fixedandstainedwith crystal violet, andthe
surviving fractions were determined. The clonogenic
(plating efficiency) assay is a direct and accurate method
to determine the survival of cells following their exposure
to a cytotoxic drug (Sellers, J. R.; Cook, S.; Goldmacher,
V. S. J. Immunol. Methods, 1994, 172, 255–264). We
found indirect methods, such as MTT (Mosmann, T. J.
Immunol. Methods, 1983, 65, 55–63) andSRB (Skehan,
P.; Storeng, R.; Scudiero, D.; Monks, A.; McMahon, J.,
Vistica, D., Warren, J. T.; Bokesch, H.; Kenney, S.;
Boyd, M. R. J. Natl. Cancer Inst., 1990, 82, 1107–1112)
less accurate andreproducible when usedfor evaluation
of highly cytotoxic compounds. The IC50 values varied
dramatically depending on the conditions, such as the
cell number, andthe length of cell culturing following
their exposure to a drug.
4. Baloglu, E.; Kingston, D. G. I. J. Nat. Prod. 1999, 62,
1448–1472.
5. (a) Ojima, I.; Geng, X.; Wu, X.; Qu, C.; Borella, C. P.;
Xie, H.; Wilhelm, S. D.; Leece, B. A.; Bartle, L. M.;
Goldmacher, V. S.; Chari, R. V. J. J. Med. Chem. 2002,
45(26), 5620–5623; (b) Safavy, A.; Bonner, J. A.; Waksal,
H. W.; Buchsbaum, D. J.; Gillespie, G. Y.; Khazaeli, M.
B.; Arani, R.; Chen, D.-T.; Carpenter, M.; Raisch, K. P.
Bioconjugate Chem. 2003, 14, 302–310; (c) Wahl, A. F.;
Donaldson, K. L.; Mixan, B. J.; Trail, P. A.; Siegall, C. B.
Int. J. Cancer 2001, 93, 590–600; (d) Milas, L.; Mason, K.
A.; Hunter, N.; Li, C.; Wallace, S. Int. J. Radiat. Oncol.
Biol. Phys. 2003, 55(3), 707–712; (e) Safavy, A.; Raisch, K.
P.; Khazaeli, M. B.; Buchsbaum, D. J.; Bonner, J. A. J.
Med. Chem. 1999, 42, 4919–4924; (f) Gilbert, C. W.;
McGowan, E. B.; Seery, G. B.; Black, K. S.; Pegram, M.
D. J. Exp. Therapeutics 2003, 3, 27–35; (g) Sledge, G. W.,
Jr. Semin. Oncol. 2003, 30(2), 19–21; (h) Jaime, J.; Page,
M. Anticancer Res. 2001, 21, 1119–1128; (i) Kirschberg, T.
A.; Vandeusen, C. L.; Rothbard, J. B.; Yang, M.; Wender,
P. A. Org. Lett. 2003, 5(19), 3459–3462.
6. Miller, M. L.; Roller, E. E.; Baloglu, E.; Leece, B. A.;
Goldmacher, V. S.; Chari, R. V. J. 226th ACS Nat.
Meeting, New York, NY, USA, September 7–11, 2003,
MEDI-260.
7. (a) Baloglu, E.; Hoch, J. M.; Chatterjee, S. K.; Ravindra,
R.; Bane, S.; Kingston, D. G. I. Bioorg. Med. Chem. 2003,
11, 1557–1568; (b) Ojima, I.; Wang, T.; Miller, M. L.; Lin,
S.; Borella, C. P.; Geng, X.; Pera, P.; Bernacki, R. J.
Bioorg. Med. Chem. Lett. 1999, 9, 3423–3428; (c) King-
11. Kingston, D. G. I.; Jagtap, P. J.; Yuan, H.; Samala, L. In
Herz, W., Falk, W., Kirby, G. W., Eds.; Progress in the
Chemistry of Organic Natural Products; Springer: Wien,
2002; Vol. 84, andreferences citedtherein.